SCHEMBL15044016

SCHEMBL15044016

C[C@@H](CN(C(N)=O)C(=O)NCC1=CCC(Cl)C=C1)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15044483 0.81
SCHEMBL10055489 0.71 CYP2C9 (0.50)
SCHEMBL10055215 0.69 SMN1; SMN2 (0.46)
SCHEMBL10057071 0.67 WDR5 (0.37)
SCHEMBL10056850 0.65 CYP2D6 (0.43)
SCHEMBL10056326 0.65 ALDH1A1 (0.37)
SCHEMBL15044357 0.65 TDP1 (0.39)
SCHEMBL10056291 0.60 TSHR (0.56)
SCHEMBL10055319 0.60 CYP2C9 (0.48)
SCHEMBL10057054 0.59 SMN1; SMN2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013089212-A1 SUBSTITUTED TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 塩野義製薬株式会社 (JP) 2013-06-20 WO disclosed